These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15841160)

  • 21. Hyperhomocysteinemia and Cardiovascular Disease: Is the Adenosinergic System the Missing Link?
    Paganelli F; Mottola G; Fromonot J; Marlinge M; Deharo P; Guieu R; Ruf J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine: an emerging age-related cardiovascular risk factor.
    Moustapha A; Robinson K
    Geriatrics; 1999 Apr; 54(4):41, 44-6, 49-51. PubMed ID: 10212627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
    Alemán G; Tovar AR; Torres N
    Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolism of homocysteine and its relationship with cardiovascular disease.
    Aguilar B; Rojas JC; Collados MT
    J Thromb Thrombolysis; 2004 Oct; 18(2):75-87. PubMed ID: 15789174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Homocysteine and cardiovascular disease: biological mechanisms, observational epidemiology, and the need for randomized trials.
    Splaver A; Lamas GA; Hennekens CH
    Am Heart J; 2004 Jul; 148(1):34-40. PubMed ID: 15215789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Homocysteinemia and vascular disease--a new risk factor is born].
    Reis RP; Luís AS
    Rev Port Cardiol; 1999 May; 18(5):507-14. PubMed ID: 10418265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis].
    Wuillemin WA; Solenthaler M
    Vasa; 1999 Aug; 28(3):151-5. PubMed ID: 10483317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Research advances in the treatment of hyperhomocysteinemia].
    Cheng S; Feng J; Wang X
    Sheng Li Ke Xue Jin Zhan; 2011 Oct; 42(5):329-34. PubMed ID: 22242398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperhomocysteinemia as a vascular risk factor in chronic hemodialysis patients].
    Trimarchi H; Young P; Díaz ML; Schropp J; Forrester M; Freixas E
    Medicina (B Aires); 2005; 65(6):513-7. PubMed ID: 16433478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine-Induced Endothelial Dysfunction.
    Lai WK; Kan MY
    Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid fortification ameliorates hyperhomocysteinemia caused by a vitamin B₆-deficient diet supplemented with L-methionine.
    Yamamoto K; Isa Y; Nakagawa T; Hayakawa T
    Biosci Biotechnol Biochem; 2012; 76(10):1861-5. PubMed ID: 23047096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homocysteine and essential hypertension.
    Rodrigo R; Passalacqua W; Araya J; Orellana M; Rivera G
    J Clin Pharmacol; 2003 Dec; 43(12):1299-306. PubMed ID: 14615465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats.
    Distrutti E; Mencarelli A; Santucci L; Renga B; Orlandi S; Donini A; Shah V; Fiorucci S
    Hepatology; 2008 Feb; 47(2):659-67. PubMed ID: 18098324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine and risk for atherothrombotic events.
    Puddu P
    Cardiologia; 1999 Jul; 44(7):627-31. PubMed ID: 10476587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronic complication of diabetes and homocysteine].
    Idzior-Waluś B; Cieślik G
    Przegl Lek; 2000; 57(12):732-5. PubMed ID: 11398598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
    Hwang SY; Siow YL; Au-Yeung KK; House J; O K
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine, B vitamins, and cardiovascular disease.
    Quinlivan EP; Gregory JF
    N Engl J Med; 2006 Jul; 355(2):206; author reply 209-11. PubMed ID: 16838446
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunoregulatory effects of homocysteine on cardiovascular diseases.
    Dai J; Wang X
    Sheng Li Xue Bao; 2007 Oct; 59(5):585-92. PubMed ID: 17940698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Homocysteine. The cardiovascular risk factor of the next millennium?].
    Suárez García I; Gómez Cerezo JF; Ríos Blanco JJ; Barbado Hernández FJ; Vázquez Rodríguez JJ
    An Med Interna; 2001 Apr; 18(4):211-7. PubMed ID: 11496543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular oxidant stress and inflammation in hyperhomocysteinemia.
    Papatheodorou L; Weiss N
    Antioxid Redox Signal; 2007 Nov; 9(11):1941-58. PubMed ID: 17822365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.